Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system

X Pan, SR Ikeda and DL Lewis

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912, USA.

Modulation of neuronal ion channels by the cloned rat brain CB1 cannabinoid receptor was investigated with the use of a heterologous neuronal expression system. Transient expression of the rat brain CB1 cannabinoid receptor was accomplished through microinjection of in vitro transcribed cRNA into the cytoplasm of enzymatically dissociated adult rat superior cervical ganglion neurons. The cannabimimetic aminoalkylindole WIN 55,212-2 inhibited whole-cell Ca2+ currents in neurons injected 16-25 hr previously with rat brain CB1 cannabinoid receptor cRNA. Inhibition of the Ca2+ current was voltage and concentration dependent, with a maximal inhibition of 73% and an IC50 value of 47 nM. The synthetic cannabinoid analogue CP55,940 also inhibited Ca2+ currents, with a maximal inhibition of 38% and an IC50 value of 7 nM. Ca2+ current inhibition was blocked by inclusion of guanosine-5'-O-(2-thiodiphosphate) in the intracellular patch pipette solution or by pretreatment with pertussis toxin. Pretreatment with the N-type Ca2+ channel antagonist omega-conotoxin GVIA reduced the inhibition by 100 nM WIN 55,212-2 from 44% to 6%, indicating that N- type Ca2+ channels are a target of cannabinoid action. On washout of WIN 55,212-2, the Ca2+ current amplitude "overrecovered" in 47% of the neurons tested. Anandamide, the endogenous cannabimimetic compound, had an inconsistent effect on the voltage-dependent Ca2+ currents in the majority of neurons microinjected with cannabinoid receptor cRNA. Ca2+ channels were a specific effector target of the cannabinoid receptor, as two different K+ currents, the M current and the A current, were not modulated by the cannabimimetic WIN 55,212-2.

Volume 49, Issue 4, pp. 707-714, 04/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				L. M. Johanek and D. A. Simone Cannabinoid Agonist, CP 55,940, Prevents Capsaicin-Induced Sensitization of Spinal Cord Dorsal Horn Neurons J Neurophysiol, February 1, 2005; 93(2): 989 - 997. [Abstract] [Full Text] [PDF]

				J. Guo and S. R. Ikeda Endocannabinoids Modulate N-Type Calcium Channels and G-Protein-Coupled Inwardly Rectifying Potassium Channels via CB1 Cannabinoid Receptors Heterologously Expressed in Mammalian Neurons Mol. Pharmacol., March 1, 2004; 65(3): 665 - 674. [Abstract] [Full Text] [PDF]

				I. A. Khasabova, C. Harding-Rose, D. A. Simone, and V. S. Seybold Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons J. Neurosci., February 18, 2004; 24(7): 1744 - 1753. [Abstract] [Full Text] [PDF]

				M. I. Davis, J. Ronesi, and D. M. Lovinger A Predominant Role for Inhibition of the Adenylate Cyclase/Protein Kinase A Pathway in ERK Activation by Cannabinoid Receptor 1 in N1E-115 Neuroblastoma Cells J. Biol. Chem., December 5, 2003; 278(49): 48973 - 48980. [Abstract] [Full Text] [PDF]

				A. B. El-Remessy, I. E. Khalil, S. Matragoon, G. Abou-Mohamed, N.-J. Tsai, P. Roon, R. B. Caldwell, R. W. Caldwell, K. Green, and G. I. Liou Neuroprotective Effect of(-){Delta}9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity: Involvement of Peroxynitrite Am. J. Pathol., November 1, 2003; 163(5): 1997 - 2008. [Abstract] [Full Text] [PDF]

				D. P. Hurst, D. L. Lynch, J. Barnett-Norris, S. M. Hyatt, H. H. Seltzman, M. Zhong, Z.-H. Song, J. Nie, D. Lewis, and P. H. Reggio N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) Interaction with LYS 3.28(192) Is Crucial for Its Inverse Agonism at the Cannabinoid CB1 Receptor Mol. Pharmacol., December 1, 2002; 62(6): 1274 - 1287. [Abstract] [Full Text] [PDF]

				A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Pharmacol. Rev., June 1, 2002; 54(2): 161 - 202. [Abstract] [Full Text] [PDF]

				J. Nie and D. L. Lewis Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration J. Neurosci., November 15, 2001; 21(22): 8758 - 8764. [Abstract] [Full Text] [PDF]

				D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens J. Neurosci., January 1, 2001; 21(1): 109 - 116. [Abstract] [Full Text] [PDF]

				P. Schweitzer Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons J. Neurosci., January 1, 2000; 20(1): 51 - 58. [Abstract] [Full Text] [PDF]

				M. Glass and J. K. Northup Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors Mol. Pharmacol., December 1, 1999; 56(6): 1362 - 1369. [Abstract] [Full Text]

				S. D. McAllister, G. Griffin, L. S. Satin, and M. E. Abood Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 618 - 626. [Abstract] [Full Text]

				C. Vasquez and D. L. Lewis The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors J. Neurosci., November 1, 1999; 19(21): 9271 - 9280. [Abstract] [Full Text] [PDF]

				J. G. Netzeband, S. M. Conroy, K. L. Parsons, and D. L. Gruol Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture J. Neurosci., October 15, 1999; 19(20): 8765 - 8777. [Abstract] [Full Text] [PDF]

				D. Gebremedhin, A. R. Lange, W. B. Campbell, C. J. Hillard, and D. R. Harder Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2085 - H2093. [Abstract] [Full Text] [PDF]

				M. Shen and S. A. Thayer Delta 9-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture Mol. Pharmacol., January 1, 1999; 55(1): 8 - 13. [Abstract] [Full Text]

				X. Pan, S. R. Ikeda, and D. L. Lewis SR 141716A Acts as an Inverse Agonist to Increase Neuronal Voltage-Dependent Ca2+ Currents by Reversal of Tonic CB1 Cannabinoid Receptor Activity Mol. Pharmacol., December 1, 1998; 54(6): 1064 - 1072. [Abstract] [Full Text]

				C. Sánchez, I. Galve-Roperh, D. Rueda, and M. Guzmán Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the Delta 9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes Mol. Pharmacol., November 1, 1998; 54(5): 834 - 843. [Abstract] [Full Text]

				A. K. Filippov, T. E. Webb, E. A. Barnard, and D. A. Brown P2Y2 Nucleotide Receptors Expressed Heterologously in Sympathetic Neurons Inhibit Both N-Type Ca2+ and M-Type K+ Currents J. Neurosci., July 15, 1998; 18(14): 5170 - 5179. [Abstract] [Full Text] [PDF]

				W. Twitchell, S. Brown, and K. Mackie Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons J Neurophysiol, July 1, 1997; 78(1): 43 - 50. [Abstract] [Full Text] [PDF]

				M. Shen, T. M. Piser, V. S. Seybold, and S. A. Thayer Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures J. Neurosci., July 15, 1996; 16(14): 4322 - 4334. [Abstract] [Full Text] [PDF]